Oral Squamous Cell Carcinoma with neck metastases, Oropharyngeal Squamous Cell Carcinoma research hub

An open-label, non-randomized, single center, single dose, exploratory phase II trial of FG001 (an imaging agent) in combination with transoral robotic surgery for oropharyngeal squamous cell carcinoma and neck dissection surgery for oral squamous cell carcinoma with regional lymph node metastases

This study looks at a special dye called FG001 to help surgeons find cancer better during operations for mouth and throat cancer. It aims to see if the dye can light up cancer cells, making them easier to remove completely.